BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 15454139)

  • 21. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedures: FRANSENODE trial.
    Rodier JF; Velten M; Wilt M; Martel P; Ferron G; Vaini-Elies V; Mignotte H; Brémond A; Classe JM; Dravet F; Routiot T; de Lara CT; Avril A; Lorimier G; Fondrinier E; Houvenaeghel G; Avigdor S
    J Clin Oncol; 2007 Aug; 25(24):3664-9. PubMed ID: 17485709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of sentinel node mapping for cancer of the colon: 'to map or not to map".
    Thomas KA; Lechner J; Shen P; Waters GS; Geisinger KR; Levine EA
    Am Surg; 2006 Jul; 72(7):606-11; discussion 611-2. PubMed ID: 16875082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between concordance of tracers, order of harvest, and presence of metastases in sentinel lymph nodes with breast cancer.
    Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A; Ebihara S
    Ann Surg Oncol; 2005 Jun; 12(6):497-503. PubMed ID: 15864480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
    Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
    Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
    Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
    Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning curves and certification for breast cancer lymphatic mapping.
    Bass SS; Cox CE; Reintgen DS
    Surg Oncol Clin N Am; 1999 Jul; 8(3):497-509. PubMed ID: 10448692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
    Murawa D; Hirche C; Dresel S; Hünerbein M
    Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Added value of blue dye in sentinel node biopsy for breast cancer.
    Snoj M; Golouh R; Movrin-Stanovnik T; Vidergar-Kralj B
    J Exp Clin Cancer Res; 2003 Dec; 22(4):551-5. PubMed ID: 15053296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement of peritumoral and subareolar injection in breast cancer sentinel lymph node biopsy.
    Noguchi M; Inokuchi M; Zen Y
    J Surg Oncol; 2009 Aug; 100(2):100-5. PubMed ID: 19479943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
    Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
    Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study.
    McMasters KM; Wong SL; Martin RC; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Laidley AL; McGlothin TQ; Ley PB; Brown CM; Glaser RL; Pennington RE; Turk PS; Simpson D; Cerrito PB; Edwards MJ;
    Ann Surg; 2001 May; 233(5):676-87. PubMed ID: 11360892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subareolar versus peritumoral injection for location of the sentinel lymph node.
    Klimberg VS; Rubio IT; Henry R; Cowan C; Colvert M; Korourian S
    Ann Surg; 1999 Jun; 229(6):860-4; discussion 864-5. PubMed ID: 10363900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
    Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
    Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concordance between peri-areolar blue dye and peri-incisional radiotracer injections for sentinel node mapping in patients with a history of primary breast cancer excisonal biopsy.
    Mehrabibahar M; Azizi S; Jangjoo A; Saremi E; Kakhki VR; Sadeghi R; Chicken DW; Keshtgar M
    Acta Chir Belg; 2014; 114(1):31-3. PubMed ID: 24720135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
    Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
    Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma.
    Ariyan S; Ariyan C; Farber LR; Fischer DS; Flynn SD; Truini C
    J Am Coll Surg; 2004 Jun; 198(6):924-32. PubMed ID: 15194074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma.
    Cloyd JM; Wapnir IL; Read BM; Swetter S; Greco RS
    J Surg Oncol; 2014 Dec; 110(7):888-92. PubMed ID: 25124992
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer.
    Derossis AM; Fey J; Yeung H; Yeh SD; Heerdt AS; Petrek J; VanZee KJ; Montgomery LL; Borgen PI; Cody HS
    J Am Coll Surg; 2001 Nov; 193(5):473-8. PubMed ID: 11708502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Lymph nodes mapping for detection of sentinel nodes in patients with papillary thyroid cancer].
    Nakano S; Uenosono Y; Ehi K; Arigami T; Higashi Y; Maeda T; Kijima Y; Natsugoe S; Aikou T
    Gan To Kagaku Ryoho; 2004 May; 31(5):801-4. PubMed ID: 15170997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.